Novo Nordisk's experimental obesity drug CagriSema shows blood pressure benefits

reuters.com/business/healthcare-pharmaceuticals/novo-nordisks-experimental-obesity-drug-cagrisema-shows-blood-pressure-benefits-2025-11-06

This story appeared on reuters.com, 2025-11-06 19:36:39.388000.
The Entire Business World on a Single Page. Free to Use →